Non-Hodgkin lymphomas with systemic presentation in patients with HIV infection;Linfomas no hodgkinianos de presentación sistémica e infección por VIH

Revista Clinica Espanola

Volumn 204, Issue 6, 2004, Pages 303-307

  Segura Huerta, A ^a   Lopez Tendero P ^a   Romera Barroso, B ^a   Yuste Izquierdo, A L ^a   Girones Sarrio R ^a   Perez Fidalgo J A ^a   Gomez Codina J ^a   Lopez Aldeguer J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

HIV infection; Non Hodgkin's lymphomas; Prognostic factors

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; NUCLEOSIDE ANALOG; PREDNISONE; VINCRISTINE SULFATE;

ADULT; ARTICLE; B CELL LYMPHOMA; BLOOD TOXICITY; BONE MARROW BIOPSY; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LARGE CELL LYMPHOMA; MALE; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PROGNOSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 3142684770     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062268     Document Type: Article

References (34)

1. Centers for Disease Control. Revision of the CDC surveillance definition for adquired inmunodeficience syndrome. MMWR 1987;36:1S.
2. Revised classification system for human immunodeficiency virus infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:RR17.
3. Serraino D, Salamina G, Franceschi S, Dubois D, La Vecchia C, Brunet JB, et al. The epidemiology of AIDS-asociated non-Hodgkin's lymphoma in the World Health Organization European Region. Br J Cancer 1992;66:911-6.
4. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human inmunodeficience virus type 1. J Natl Cancer Inst 1994;86:1711-6.
5. Jones SL, Hanson DL, Ward JW. Effect of antiretroviral therapy on recent trends in cancer among HIV-infected persons. Second National AIDS malignancy Conference, Bethesda 1998. J AIDS 1999;21(Suppl 1):S18-S22.
6. Rubio R. Impacto de la terapia antirretroviral altamente eficaz en la historia de los linfomas no hodgkinianos asociados al sida. AIDS Cyber J 2000;3-9.
7. National Cancer Institute Sponsored Study of Classification of Non-Hodgkin's Lymphomas. Summary and description of a Working Formulation for clinical usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 1982;40:2112-35.
8. Carbone PP, Kaplan HS, Musshoff k, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's disease staging. Cancer Res 1971;31: 1860-1.
9. Shipp M, Harrington D, Anderson J, Armitage J, Bonadonna G, Brittinger G, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The international NHL Prognostic Fators Project. N Engl J Med 1993; 329:987-94.
10. Jagannath S, Velasquez WS, Tucker SL, Fuller LM, McLaughin PW, Manning JT, et al. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. J Clin Oncol 1986;4:859-65.
11. World Health Organization. Handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979.
12. Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972 (serie B); 3:187-220.
14. Armitage Jo, Dick FR, Corder MP, Garneau SC, Platz CE, Slymen DJ, et al. Predicting terapeutic outcome in patients with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer 1982;50:1695-702.
15. Porcu P, Caligiuri A. Acquired inmunodeficiency syndrome-related lymphomas: future directions. Semin Oncol 2000;27:454-62.
16. Ribera Santasusana, JM. Epidemiología, etiología y patogenia de los linfomas en pacientes infectados por el VIH. En: Díaz Mediavilla J, Berenguer Berenguer J, Miralles Martín P, editores. Linfomas en pacientes infectados por el virus de la inmunodeficiencia humana. 1.a ed. Madrid: Ediciones Arán; 2000; p. 40.
17. Lyons SF, Liebowitz DN. The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol 1998;25:461-75.
18. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associates herpesvirus-like DNA sequences in AIDS-related body-cavity-cased lymphomas. N Engl J Med 1995;332:1186-91.
19. Ziegler JL, Beckstead JA, Volderding PA, Abgrams DI, Levine AM, Lukes RJ, et al. Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 1984;311:565-70.
20. Levine Am. Acquires inmunodeficiency syndrome related lymphoma. Blood 1992;80:8-20.
21. Knowles DM, Chamulak G, Subar M, Pelicci PG, Dugan M, Burke JS, et al. Clinico-pathologic, inmunophenotypic, and molecular genetic analysis of AIDS associated lymphoid neoplasia. Clinical and biological implications. Pathol An 1988;2:33-67.
22. Rubio R, Puldo F, Pintado V, Díaz-Mediavilla J, Flores E, Serrano M, et al. Linfomas no hodgkinianos asociados al síndrome de la inmunodeficiencia adquirida. Estudio clínico multicé ntrico de 77 casos. Med Clin (Barc) 1995; 104:481-6.
23. Kaplan MH, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261:719-24.
24. Ribera JM, Tomás J, Oriol A, Raventós A, Sierre G, et al. Linfomas no hodgkinianos en pacientes con infección por el virus de la inmunodeficiencia humana. Sangre 1994;3(6):429-34.
25. Von Gunten CF, Von Roenn JH. Clinical aspects of human inmunodeficiency virus-related lymphoma. Curr Opin Oncol 1992:4(5):894-9.
26. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;108:744-53.
27. Sawka CA, Shepherd FA, Brandwein J, Burkes RL, Sutton DM, Warnwer E. Treatment of AIDS-related non Hodgkin's lymphoma with twelve week chemotherapy program. Leuk Lymphoma 1992;8(3):213-20.
28. Gabarre J, Lepage E, Thyss A, Tubiana R, Bastion Y, Schlafer D, et al. Chemotherapy combined with zidovudine and GM-CSF in human inmunodeficiency virus-related non-Hodgkin's lymphoma. Ann Oncol 1995; 6(10):1025-32.
29. Schurmann D, Grunewald T, Weiss R, Jautzke G, Pohle HD, Ruf B. Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol. Eur J Haematol 1995;54(2):73-7.
30. Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, et al. Low-dose chemotherpy with central nervous system and zidovudine maintenance in AIDS-related lymphoma. A prospective multiinstitutional trial. JAMA 1991;266(1):84-8.
31. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, et al. Low dose methotrexate, bleomicyn, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired inmunodeficiency syndrome-related lymphoma. Effect on human inmunodeficiency vinis and serum interleukin-6 levels over time. Cancer 1996;78(3): 517-26.
32. Kaplan LD, Straus DJ, Testa MA, Von Roem J, Dezule BJ, Cooley TP, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human inmunodeficiency virus infection. National Institute of Allergy and Infectious Diseases. AIDS Clinical Trials Group. N Engl J Med 1997;336(23):1641-8.
33. Vaccher E, Spina M, Santarrossa S, et al. Concomitant CHOP chemotherapy (CT) and higly active antiretroviral therapy (HAART) in patients with HIV-related non Hodgkin's lymphoma. Int Conf AIDS 1998;12:320 (abstract no. 22289).
34. Cingolani A, Alba L, Ammassari A, et al. Less agressive disease and longer survival in AIDS-related lymphomas during HAART. 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; 2000.